Rakovina Therapeutics Expands Global Reach with Frankfurt Stock Exchange Listing

Date:

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks’ Smart Score a data driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts’ recommendations with Your Smart Portfolio

An update from Rakovina Therapeutics Inc ( (TSE:RKV) ) is now available.

Rakovina Therapeutics Inc. has announced its listing on the Frankfurt Stock Exchange, marking a significant milestone that enhances its visibility and accessibility to European and global investors. This strategic move complements its existing listing on the TSX Venture Exchange, facilitating broader participation in its mission to innovate cancer drug discovery. By leveraging AI-driven platforms, Rakovina aims to establish itself as a leader in oncology drug discovery, with the global DNA-damage response therapy market expected to reach $18 billion annually…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...